Symbols / CERE
CERE Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2024-03-04 13:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Cerence AI (NASDAQ: CRNC) unveils dealer and owner agents debuting at CES 2026 - Stock Titan hu, 11 Dec 2025 08
- ROSEN, A LEADING NATIONAL FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE - TradingView ue, 22 Apr 2025 07
- AI chipmaker Cerebras announces CFIUS clearance, a key step toward IPO - CNBC Mon, 31 Mar 2025 07
- Here's Why Cerevel Therapeutics Stock Is Shooting Through the Roof Today - The Motley Fool ue, 29 Jun 2021 07
- Cerevel options trading surge before AbbVie deal news raises eyebrows - Reuters Fri, 08 Dec 2023 08
- Cerevel Therapeutics: Time For A Risk Arbitrage Play? - Seeking Alpha ue, 04 Jun 2024 07
- AbbVie to buy Cerevel in $8.7B bet on brain drugs - BioPharma Dive Wed, 06 Dec 2023 08
- AbbVie Buys Cerevel Therapeutics for $8.7B, Bolstering Neuroscience Portfolio - Investopedia hu, 07 Dec 2023 08
- 3 Biotech Stocks That Could Boom or Bust by 2025 - Nasdaq ue, 21 Nov 2023 08
- Why Is Cyngn (CYN) Stock Up 73% Today? - InvestorPlace hu, 07 Dec 2023 08
- AbbVie to buy drug developer Cerevel for $8.7 billion - Reuters Wed, 06 Dec 2023 08
- Cerevel Therapeutics: CNS Specialist's Delayed Readouts A Potential Red Flag (NASDAQ:CERE) - Seeking Alpha Fri, 10 Mar 2023 08
- Here's What's Pushing Cerevel Therapeutics Stock Lower Today - The Motley Fool Fri, 02 Jul 2021 07
- AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion - CNBC Wed, 06 Dec 2023 08
- Markets News, Dec. 7, 2023: Big Tech Surges, Lifting Nasdaq as the Dollar Slides - Investopedia hu, 07 Dec 2023 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for CERE
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|